Host-directed adjunctive therapies everolimus and CC-11050 are safe and reasonably well-tolerated in adults with pulmonary tuberculosis infection.
Rita AghjayanEditor https://www.pulmonologyadvisor.com
Rita Aghjayan is the editor of Hematology Advisor. She holds a BS in biology with minors in physics and chemistry from Pace University in New York. Prior to joining Haymarket, Rita conducted research both in quantum physics and microbial ecology.